You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Coronavirus Vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial in Changsha (Recombinant Novel Coronavirus vaccine (CHO Cells))

Completed
  • COVID-19
  • Recombinant Novel Coronavirus vaccine (CHO Cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 6, 2023

COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))

Recruiting
  • COVID-19
  • Recombinant new coronavirus vaccine (CHO cell)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Oct 10, 2022

COVID-19 Trial in Taizhou (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Recombinant Novel Coronavirus

Completed
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo
  • Taizhou, Jiangsu, China
    Taixing City center for Disease Control and Prevention
Oct 28, 2022

Coronavirus Trial (OVX033, Saline solution)

Not yet recruiting
  • Coronavirus
  • OVX033
  • Saline solution
  • (no location specified)
Nov 14, 2023

COVID-19 Trial in Yancheng (Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml, Recombinant Novel

Active, not recruiting
  • COVID-19
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.5ml
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) 0.3ml
  • Yancheng, Jiangsu, China
    Funing Center for Disease Control and Prevention
Oct 28, 2022

Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel

Not yet recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • (no location specified)
Sep 5, 2023

Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)

Enrolling by invitation
  • Corona Virus Disease 2019(COVID-19)
  • 0.3ml of mRNA vaccine
  • Chengdu, China
    West China Second University Hospital
Oct 3, 2022

COVID-19 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell))

Recruiting
  • COVID-19
  • Recombinant new coronavirus vaccine (CHO cell)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jun 2, 2023

Coronavirus Trial in Wuhu (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant

Active, not recruiting
  • Coronavirus
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Recombinant novel coronavirus protein vaccine (CHO cells)
  • Wuhu, Anhui, China
    Wannan Medical College Yijishan Hospital
May 6, 2023

COVID-19 Vaccine Trial in Ciudad autónoma de Buenos Aires, Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aires

Active, not recruiting
  • COVID-19 Vaccine
  • Ad5-nCov
  • Ciudad autónoma de Buenos Aires, Buenos Aires, Argentina
  • +2 more
Sep 28, 2022

COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)

Not yet recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901e
  • Halifax, Nova Scotia, Canada
  • +3 more
Dec 10, 2022

COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)

Recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901a
  • Halifax, Nova Scotia, Canada
  • +6 more
Nov 16, 2022

Coronavirus Disease 2019 Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group)

Completed
  • Coronavirus Disease 2019
  • Recombinant new coronavirus vaccine (CHO cell) group
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Oct 21, 2021

COVID-19, Coronavirus Infections, Respiratory Tract Infections Trial in Russian Federation (Subunit recombinant vaccine for the

Active, not recruiting
  • COVID-19
  • +3 more
  • Subunit recombinant vaccine for the prevention of coronavirus infection
  • Placebo
  • Moscow, Russian Federation
  • +5 more
Feb 9, 2023

COVID-19 Trial in Hangzhou (Recombinant novel coronavirus vaccine (CHO cells))

Recruiting
  • COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial Center for Disease Control and Prevention
Jan 11, 2022

COVID-19 Trial in Hangzhou (Recombinant novel coronavirus vaccine (CHO cells))

Active, not recruiting
  • COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial Center for Disease Control and Prevention
Jan 11, 2022

COVID-19 Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Placebo)

Not yet recruiting
  • COVID-19
  • Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
  • Placebo
  • (no location specified)
Sep 22, 2023

Prevention of COVID-19 Trial in Changsha (Recombinant novel coronavirus vaccine (CHO cells))

Active, not recruiting
  • Prevention of COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Feb 6, 2022

Coronavirus Disease 2019 Trial in Changsha (Tetravalent influenza virus lysis vaccine, Recombinant new coronavirus vaccine (CHO

Recruiting
  • Coronavirus Disease 2019
  • Tetravalent influenza virus lysis vaccine
  • Recombinant new coronavirus vaccine (CHO cell) group
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Nov 3, 2021

Prevention of COVID-19 Trial in Changsha (Recombinant novel coronavirus vaccine (CHO cells))

Active, not recruiting
  • Prevention of COVID-19
  • Recombinant novel coronavirus vaccine (CHO cells)
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention Preve
Feb 6, 2022

COVID-19, Vaccine Reaction Trial in Oxford (Spermidine or Placebo)

Recruiting
  • COVID-19
  • Vaccine Reaction
  • Spermidine or Placebo
  • Oxford, United Kingdom
    University of Oxford
Jul 13, 2022

Coronavirus Trial in Changsha (Recombinant new coronavirus vaccine (CHO cell) group, Recombinant new coronavirus vaccine (CHO

Recruiting
  • Coronavirus
  • Recombinant new coronavirus vaccine (CHO cell) group
  • Recombinant new coronavirus vaccine (CHO cells) placebo group
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Jul 19, 2021

COVID-19, Immunologic Factors, Coronavirus Infections Trial in Moscow, Saint-Petersburg (Subunit recombinant vaccine for the

Active, not recruiting
  • COVID-19
  • +3 more
  • Subunit recombinant vaccine for the prevention of coronavirus infection
  • Placebo
  • Moscow, Russian Federation
  • +2 more
Dec 15, 2021

Coronavirus Infections, Vaccine Trial in Russian Federation (CoviVac vaccine (inactivated whole-virion concentrated purified)

Recruiting
  • Coronavirus Infections
  • Vaccine
  • CoviVac vaccine (inactivated whole-virion concentrated purified) manufactured by FSBSI "Chumakov FSC R&D IBP RAS"
  • The data from volunteers from the control group
  • Kirov, Russian Federation
  • +9 more
Jul 8, 2022

COVID-19 Trial in Tashkent (Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells), Recombinant Novel

Recruiting
  • COVID-19
  • Omicron-Delta Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Recombinant Novel Coronavirus Protein Vaccine (CHO cells)
  • Tashkent, Uzbekistan
    Uzbekistan, Tashkent city, Said baraka street 10
Nov 11, 2022